Heading Title
-
CompaniesSun Pharma
Sun Pharma Acquires Uractiv portfolio from Fiterman Pharma in Romania
by adminby adminSummary Indian multinational pharma company Sun Pharmaceutical on Friday announced that one of its subsidiaries, S.C. Terapia S.A, has acquired the Uractiv portfolio from Fiterman Pharma in Romania. The Uractiv …
-
World Environment 2022: The World Environment Day is celebrated on June 5 of each year with the aim to mark the importance of nature and raise awareness for its protection. World …
-
IndiaMerger / Acquisition
Dr. Reddy’s sells four Treatment Category Products to Torrent Pharma.
by adminby adminSummary : Torrent Pharmaceuticals, located in Ahmedabad, said on Thursday that it had agreed to buy four brands from Dr Reddy’s Laboratories Ltd. (DRL). Torrent’s presence in the therapeutic area …
-
-
RegulatoryU.S FDA
TherapeuticsMD Receives U.S. Receives US Food and Drug Administration (FDA) Approval for the Supplemental New Drug Application (sNDA) for ANNOVERA
by adminby adminSummary : ANNOVERA is the only FDA-approved procedure-free, long-lasting, reversible birth control – -With this approval, the Company expects a significant reduction in its manufacturing batch rejections and an increase …
-
CompaniesEli LillyRegulatoryU.S FDA
Eli Lilly Gets FDA Approval for Diabetic Drug Tirzepatide
by adminby adminSummary : The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide. It has a dual effect, lowering …
-
Global MarketIndiaLaunch
Nichino India Introduces Insecticide ‘Orchestra’(Benzpyrimoxan) to Control Brown Plant Hopper in Rice
by adminby adminSummary : Nichino India, a subsidiary of the Japanese agrochemical company Nihon Nohyaku Co, has launched Orchestra to combat the rice Brown Plant Hopper, a pest that causes significant losses …
-
439 RC meetingCIBRC - Indian Pesticide ApprovalsRC Meeting updates
INDIAN PESTICIDE APPROVALS UPDATES – MINUTES OF THE 439TH REGISTRATION COMMITTEE (RC) MEETING HELD ON 22.04.2022
by adminby adminINDIAN PESTICIDE APPROVALS UPDATES – MINUTES OF THE 439TH REGISTRATION COMMITTEE (RC) MEETING HELD ON 22.04.2022. The 439th meeting of the Registration Committee (RC) was held under the Chairmanship of …
-
Merger / Acquisition
Marksans Pharma acquires Access Healthcare for Medical Products L.L.C , Dubai for Rs 27 cr
by adminby adminSummary: Marksans Pharma signed a share purchase agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based front-marketing and promotion company for a cash consideration …
-
Merger / Acquisition
Advanz Pharma Signs Acquisition Agreement for Intercept Pharmaceuticals
by adminby adminSummary: UK-headquartered pharma company, Advanz Pharma, has announced in a May 5, 2022 press release that it has signed an agreement with US biopharma company, Intercept Pharmaceuticals, to acquire most …
-
Bayer
BASF Launches New Herbicide, “Vesnit Complete”(Combination of Topramezone & Atrazine) for Sugarcane & Corn Farmers
by adminby adminSummary : Vesnit Complete delivers effective and broad-spectrum control of post-emergent grasses & broadleaf weeds in Sugarcane. It has a convenient formulation for long-duration control & excellent crop safety. About …
-
Daiichi SankyoRegulatoryU.S FDA
FDA Grants Regular Approval to Fam-Trastuzumab Deruxtecan-Nxki(Enhertu) for Breast Cancer
by adminby adminSummary: Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or metastatic HER2-positive breast cancer who have received a prior anti-HER2-based regimen either …
-
Merger / Acquisition
Lilly Pumps $700M into Boston-Based RNA Therapeutics Facility
by adminby adminSummary: Eli Lilly and Company is investing $700 million to build a state-of-the-art facility in Boston’s seaport as part of plans to advance its RNA-based research and development activities. The …
-
RegulatoryU.S FDA
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (Vonoprazan, Amoxicillin, Clarithromycin) and VOQUEZNA™ DUAL PAK™ (Vonoprazan, Amoxicillin) for the Treatment of H. pylori Infection in Adults
by adminby adminSummary : The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak) and one with amoxicillin (Voquezna Dual Pak), for the treatment of Helicobacter pylori (H. …
-
Bristol Myers SquibbCompaniesMerck & CoMerger / Acquisition
BMS and Merck Buy Big Into Amphista’s Protein Degradation Platform with 2.3 Billion Collab
by adminby adminSummary : Bristol Myers Squibb and Merck KGaA are diving deeper into the protein degradation pool, with both inking partnerships with Amphista Therapeutics that together could bring in $2.3 billion for …
-
RegulatoryU.S FDA
Supernus Announces FDA Approval of Qelbree®(Viloxazine) for the Treatment of ADHD in Adults
by adminby adminSummary : Qelbree (i.e. SPN-812) is a nonstimulant ADHD medication containing a serotonin norepinephrine modulating agent approved by the FDA to treat attention deficit hyperactivity disorder (ADHD or ADD) in patients 6 …
-
Bristol Myers SquibbRegulatoryU.S FDA
BMS Scores FDA Approval for Novel HCM Treatment Camzyos (Mavacamten)
by adminby adminSummary : Camzyos (mavacamten), the first FDA-approved cardiac myosin inhibitor that directly addresses the root of obstructive hypertrophic cardiomyopathy, has been authorised by the US Food and Drug Administration (HCM). …
-
CompaniesEuropeEurope Medicine Agency (EMA)Pfizer
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First ever Marketing Authorization by European Commission for both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
by adminby adminSummary : Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the European Commission (EC) has granted marketing authorization for VYDURA® (rimegepant), a calcitonin gene-related peptide …
-
EuropeEurope Medicine Agency (EMA)
Myovant Sciences Announces European Commission Approval for ORGOVYX® (Relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer
by adminby adminSummary : ORGOVYX® is the first and only oral and rogend privation therapy for advanced hormone-sensitive prostate cancerin Europe Myovant expects to secure European commercialization partner ahead of anticipated launches ORGOVYX® blocks the …
-
Summary : HYFTOR™ is the first topical treatment approved by the FDA for facial angiofibroma in individuals with tuberous sclerosis complex (TSC) 6 years and older Sirolimus is an mTOR inhibitor immunosuppressant …
-
Summary : The Venus VivaTM will now make its American premiere, having already established itself as a pioneer in the worldwide medical aesthetics sector among cutting-edge plastic surgeons, dermatologists, and …
-
Global MarketPatent LitigationPatents
FMC Corporation Wins Patent Infringement Case Against Udragon for Chlorantraniliprole
by adminby adminSummary : The Hangzhou Intermediate People’s Court in Zhejiang Province, China, awarded FMC a permanent injunction against Hangzhou Udragon Chemical Co., Ltd and Zhejiang Udragon Bioscience Co., Ltd, according to …
-
Global MarketRegulatoryU.S FDA
Sol-Gel Technologies and Galderma’s EPSOLAY® Scores US FDA Approval
by adminby adminSummary: EPSOLAY (benzoyl peroxide, cream, 5%) utilizes Sol-Gel’s proprietary microencapsulation technology for the treatment of inflammatory lesions of rosacea and is patent protected until 2040 Galderma set to commercialize EPSOLAY in …
-
Covid DrugsGileadRegulatoryU.S FDA
Gilead’s Veklury Becomes the First FDA-approved COVID-19 Treatment for Infants
by adminby adminSummary : The first treatment for COVID-19 in young children has been approved by the US Food and Drug Administration. In this situation, the FDA increased the use of Gilead …
-
Merger / AcquisitionPiramal Group
Piramal Pharma To Acquire Hemmo Pharma For Rs 775 Cr
by adminby adminSummary : Piramal Enterprises said in a regulatory filing on Wednesday that its subsidiary Piramal Pharma Ltd has signed into a deal to acquire a 100 percent ownership in Hemmo …
-
Alembic PharmaMerger / Acquisition
Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
by adminby adminSummary : The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in Aleor, which has presence across cream, gel, ointment, …
-
CompaniesIndiaMerger / AcquisitionNovartis
Dr. Reddy’s will Pay Rs 463 Crore for Novartis’ Cardiovascular Drug Cidmus (Valsartan +Sacubitril)
by adminby adminSummary Dr Reddy’s Laboratories, an Indian generic pharmaceutical company, has agreed to pay $61 million to Novartis AG for the cardiovascular brand Cidmus (approximately Rs 463 crore). This comes weeks …
-
Summary : AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson’s disease and other movement disorders. BioArctic has already announced the news through …
-
RegulatoryU.S FDA
Alymsys® (Bevacizumab-maly), a Biosimilar of Bevacizumab developed by mAbxience, has been Approved by the FDA.
by adminby adminSummary : ALYMSYS® was developed by mAbxience, a global biotech company with over a decade of experience in the development, manufacture, and commercialization of biopharmaceuticals. Bevacizumab-maly is a vascular endothelial growth …
-
Amgen Inc.Merger / Acquisition
Amgen has bought Five Prime Therapeutics for $1.9 Billion
by adminby adminSummary : Five Prime’s lead asset, Bemarituzumab, is a first-in-class, Phase 3 ready anti-FGFR2b antibody with positive data from a randomized, placebo-controlled Phase 2 study in frontline advanced gastric or …
-
Merger / Acquisition
Halozyme has agreed to Acquire Antares Pharma for $960 million.
by adminby adminSummary : Halozyme Therapeutics has announced a formal agreement to acquire all of Antares Pharma’s outstanding shares in a deal worth about $960 million in cash, or $5.60 per share. …
-
CompaniesMerger / AcquisitionPfizer
Pfizer Acquire ReViral for $ 525 Millon and its Respiratory Syncytial Virus Therapeutic Candidates Sisunatovir
by adminby adminSynopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including upfront and development milestones. Pfizer Inc. and ReViral …
-
Synopsis : GlaxoSmithKline plc and Sierra Oncology, Inc have announced that GSK will acquire Sierra Oncology, a California-based late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare …
-
Covid DrugsRegulatoryU.S FDA
The First COVID-19 Diagnostic Test Employing Breath Samples has been Approved by the US Food and Drug Administration.
by adminby adminSummary : Food and Drug Administration on Apr 14 issued an emergency use authorization It said is the first device that can detect COVID-19 in breath samples The InspectIR COVID-19 …
-
BrazilPatents
INPI Publishes an Update on the Terms of Patent Protection for Pharmaceutical and Non-Pharmaceutical Claims.
by adminby adminSummary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for updating the patent term of applications that include …
-
Patent LitigationPatents
Seagen Scores $41.8M in Enhertu Patent Case Against Daiichi Sankyo
by adminby adminSummary : A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co. LTD for infringing on a patent developed by …
-
Active Agrochemical IngredientSpirobudifenTiorantraniliprole
New Agrochemical Discovery Candidates – New ISO Published in 2022 – Spirobudifen (Tetronic acid Acaricide) & Tiorantraniliprole (Diamide insecticides)
by adminby adminNew Agrochemical Discovery Candidates – New ISO Published in 2022 Spirobudifen (Acaricide) & Tiorantraniliprole (Diamide insecticides) April 2022 BCPC – Compendium of Pesticide Common Names published new Agrochemical discovery acaricides …
-
RegulatoryU.S FDA
First Generic of Symbicort (Budesonide and Formoterol Fumarate Dihydrate) Receives FDA Approval
by adminby adminSummary : The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to treat asthma in patients 6 years and older …
-
BayerFluoxapiprolin
Australia to Approves Bayer’s Xivana Prime 20 SC Fungicide containing Fluoxapiproline
by adminby adminSummary : The Australian Pesticides and Veterinary Administration (APVMA) has proposed approval of Bayer CropScience Pvt Ltd’s fungicide Xivana Prime 20 SC, which contains 20 g/l of the new active …
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsSandoz
Sandoz and Teva Invalidate Patent and SPC of Blockbuster Apixaban
by adminby adminSummary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the corresponding SPC (SPC/GB11/042) would expire. The patent claims …
-
Global Market
The International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules has been published by Cybin.
by adminby adminSummary : Cybin (Cybin or the Company), a biopharmaceutical company focused on bringing “Psychedelics to TherapeuticsTM,” announced today that the World Intellectual Property Organization (WIPO) has published an international patent …
-
PatentsPharma Science & Research
Janssen Wins Darzalex Royalties Arbitration Battle Against Genmab
by adminby adminSummary : Janssen Pharmaceutical, a division of Johnson & Johnson, won an arbitrary victory against royalty choices arising from the licencing and marketing of daratumumab, an anti-CD38 monoclonal antibody therapy …
-
Agro Science & ResearchUPL Ltd
UPL Launches UPLIFT Dual Action Fungicide In Australia for Wheat and Barley Crop
by adminby adminSummary : UPL an Agrochemical Pioneer launches UPLIFT Fungicide, the formulation of Azoxystrobin and Prothioconazole whose action will be on wheat and barley Crop . About UPLIFT Fungicide UPLIFT is …
-
LaunchSWAL Corporation Limited
SWAL – Subsidiary of UPL Launch TRISHUK India’s First 3 Way Action Sugarcane Herbicide .
by adminby adminSummary : To solve the problems of sugar cane farmers, SWAL Corporation Limited (Part of UPL) launched Trishuk – a weed control solution. The innovative product is India’s first 3-way …
-
NufarmTrifluralin
APVMA Approves Nufarm’s TriflurX (Trifluralin Herbicide) For Use on Oat Growers
by adminby adminSummary : The use of trifluralin in 2022 and beyond was secured for oat growers after Nufarm received registration of its herbicide TriflurX from the Australian Pesticides and Veterinary Medicines …
-
KitoZymeU.S. EPA
KitoGreen, a Biopesticide Developed by KitoZyme, has received EPA Approval.
by adminby adminSummary : KitoZyme, the world’s first and largest producer of high-quality fungal chitosan, has received EPA certification for its KitoGreen products as biopesticides for a variety of applications and crops. …
-
Mankind Pharma
Mankind Pharma Makes a Move into the Agri-Tech Sector Plans to Invest Rs 200 Crore.
by adminby adminSynopsis : Mankind Pharma is planning to invest up to Rs 200 crore in the first two to three years in the agri-tech sector. Mankind Agritech Pvt Ltd, a new …
-
CompaniesMerger / AcquisitionNovartis
Sandoz Acquires Drug Delivery Device Firm Coalesce
by adminby adminSummary : Sandoz acquired the capabilities and assets of drug delivery device company, Coalesce, to further its existing portfolio of respiratory medicines and improve overall patient access. This acquisition will …
-
Global MarketMerger / Acquisition
MGK, a subsidiary of Sumitomo – Procure DeBug Brands from Agro Logistic Systems
by adminby adminSummary MGK, a subsidiary of Sumitomo Chemical Company, purchased the DeBug brand of neem products from Agro Logistic Systems. The DeBug products add to MGK’s current botanical portfolio, which includes …
-
Europe Medicine Agency (EMA)Regulatory
EMA establishes a Cancer Medicines Forum to optimize Cancer Treatments in Clinical practice
by adminby adminSummary EMA has launched the Cancer Medicines Forum (CMF) in collaboration with the European Organization for Research and Treatment of Cancer (EORTC). The forum, which brings together representatives from academic …